ATE209689T1 - Verfahren zur herstellung von steroidverbindungen - Google Patents

Verfahren zur herstellung von steroidverbindungen

Info

Publication number
ATE209689T1
ATE209689T1 AT97910556T AT97910556T ATE209689T1 AT E209689 T1 ATE209689 T1 AT E209689T1 AT 97910556 T AT97910556 T AT 97910556T AT 97910556 T AT97910556 T AT 97910556T AT E209689 T1 ATE209689 T1 AT E209689T1
Authority
AT
Austria
Prior art keywords
methyl
hydroxylation
acyloxy
carbamoyl
acyl
Prior art date
Application number
AT97910556T
Other languages
English (en)
Inventor
Stanley Michael Roberts
Jonathan Paul Eddolls
Andrew John Willetts
Anthony Atkinson
Jonathan Paul Murphy
Original Assignee
Duramed Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duramed Europ Ltd filed Critical Duramed Europ Ltd
Application granted granted Critical
Publication of ATE209689T1 publication Critical patent/ATE209689T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/02Dehydrogenating; Dehydroxylating
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97910556T 1996-11-02 1997-10-31 Verfahren zur herstellung von steroidverbindungen ATE209689T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9622884.6A GB9622884D0 (en) 1996-11-02 1996-11-02 A method for th e preparation of steroids in the pregene class
PCT/GB1997/003003 WO1998020151A1 (en) 1996-11-02 1997-10-31 A method for the preparation of steroid compounds

Publications (1)

Publication Number Publication Date
ATE209689T1 true ATE209689T1 (de) 2001-12-15

Family

ID=10802374

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97910556T ATE209689T1 (de) 1996-11-02 1997-10-31 Verfahren zur herstellung von steroidverbindungen

Country Status (5)

Country Link
EP (1) EP0941361B1 (de)
AT (1) ATE209689T1 (de)
DE (1) DE69708679D1 (de)
GB (2) GB9622884D0 (de)
WO (1) WO1998020151A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2448039A1 (en) * 2001-06-18 2002-12-27 Pharmacia & Upjohn Company Process to prepare 11.beta., 17.alpha.,21-trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate
CA2448037A1 (en) * 2001-06-18 2002-12-27 Pharmacia & Upjohn Company Process to prepare 11.beta.,17.alpha.,21-trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate
EP1587818A4 (de) * 2003-01-21 2010-10-13 Merck Sharp & Dohme 17-carbomoyloxycortisolderivate als selektive modulatoren des glucocorticoidrezeptors
CN1978457B (zh) * 2005-12-05 2010-06-09 浙江大学 6α-甲基强的松龙及其衍生物的生产方法
EP2093285B1 (de) * 2008-02-20 2016-07-06 The University of the West Indies Verfahren zur Biokatalyse unter Verwendung von Fadenpilzen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH399453A (de) * 1961-06-06 1965-09-30 Ciba Geigy Verfahren zur mikrobiologischen Oxydation von Steroiden
SE427116B (sv) * 1976-07-06 1983-03-07 Larsson Per Olof Transformation av steroider och antibiotika med immobiliserade levande mikroorganismer som aktiveras
ATE3878T1 (de) * 1980-06-21 1983-07-15 Schering Aktiengesellschaft Berlin Und Bergkamen Verfahren zur herstellung von 11-betahydroxysteroiden.
DE3133082A1 (de) * 1981-08-18 1983-03-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue hydrocortison-derivate, ihre herstellung und verwendung
EP0095894A3 (de) * 1982-05-31 1985-01-02 Ohta Seiyaku Kabushiki Kaisha. 6-Alpha Methyl Prednisolon Derivate
GB8730216D0 (en) * 1987-12-29 1988-02-03 Lepetit Spa Process for preparation of pregnenooxazolines

Also Published As

Publication number Publication date
DE69708679D1 (de) 2002-01-10
WO1998020151A9 (en) 1999-06-17
EP0941361B1 (de) 2001-11-28
EP0941361A1 (de) 1999-09-15
GB2318790B (en) 2001-04-04
WO1998020151A1 (en) 1998-05-14
GB9622884D0 (en) 1997-01-08
GB9723076D0 (en) 1998-01-07
GB2318790A (en) 1998-05-06

Similar Documents

Publication Publication Date Title
DE69120500D1 (de) Azasteroide zur Behandlung prostatischer Hypertrophie, ihre Herstellung und Verwendung
ATE229960T1 (de) Verfahren zur herstellung von 13-ether-derivaten von milbemycinen und zwischenprodukte
GR1001529B (el) Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
EP0970948A4 (de) Vitamin-d3?-derivate und aus diesen hergestellte heilmittel gegen entzündliche erkrankungen der atemwege
DE60111304D1 (de) Verfahren zur herstellung von steroid-derivaten
ATE209689T1 (de) Verfahren zur herstellung von steroidverbindungen
ES2186297T3 (es) Procedimiento para la preparacion de derivados de imidazoquinazolinona.
HUT64770A (en) New method for producing 11-keto-steroide derivatives
DE60105441D1 (de) Verfahren zur herstellung von pantoprazol und zwischenprodukte dieses verfahrens
WO1997022602A3 (en) A PROCESS FOR THE STEREOSELECTIVE REDUCTION OF α,β-UNSATURATED KETONES
KR880005145A (ko) N-글리코릴네우라민산 함유 당지질 및 그 제조방법
HUT59156A (en) Process for producing 4-amino-delta above 4-steroids and compositions comprising same
DE69616719D1 (de) Verfahren zur herstellung von taxol und seiner derivate
HU9502179D0 (en) Piperazine derivatives for producing alkyl-trazodon derivatives and process for producing them
KR940002257A (ko) 세팔로스포린 중간체의 제조방법
IT1307934B1 (it) Processo per la preparazione di derivati alchimercaptometilergolinici.
DE3579894D1 (de) Verfahren zur herstellung von aminothiazolessigsaeurederivaten.
ATE146166T1 (de) Verfahren zur herstellung von 2,2,-dimethyl-3- ((z)-2- (alkoxycarbonyl)ethenyl)cyclopropancarbonsäuree tern und zwischenprodukte
BG103398A (en) New derivatives of erythromicyn, method for their preparation and application as medicmentous forms
ATE319722T1 (de) Verfahren zur herstellung von vitamin-d analogen
ATE189887T1 (de) Vitamin-d-derivat und verfahren zu seiner herstellung
HU0001727D0 (en) Novel 1-aza-2-alkyl-6-aryl-cycloalkane compounds, process for producing them and medicaments containing the same
ATE122671T1 (de) Verfahren zur herstellung von 1,3-dioxan-4,6- dionderivaten.
ATE12391T1 (de) Verfahren zur herstellung von tetronsaeure.
ATE288917T1 (de) Verfahren zur herstellung von morphine-6- glucuronide und derivate unter verwendung von haloglucuronatester